Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Aprepitant Capsules Market Insights, Forecast to 2030

Global Aprepitant Capsules Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published Date: 2024-04-12

Pages: 90 Pages

Report ld: 2934820

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.

The global Aprepitant Capsules market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Aprepitant capsules are widely used for the prevention of nausea and vomiting during both the induction and subsequent phases of chemotherapy. With the continuous evolution of the oncology field, Aprepitant capsules have solidified their position in the market, leading to a gradual expansion of its market size. Its outstanding clinical performance has resulted in sustained sales growth, establishing it as a key player in the management of nausea and vomiting. Furthermore, as research into supportive therapies for cancer treatment advances, Aprepitant capsules hold the potential for further application and development in a broader spectrum of nausea and vomiting prevention, ultimately offering enhanced quality of life for patients.

Report Covers:

This report presents an overview of global market for Aprepitant Capsules, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Aprepitant Capsules, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Aprepitant Capsules, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aprepitant Capsules sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Aprepitant Capsules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Aprepitant Capsules sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

80mg
125mg
Other

Segment by Application

Hospital
Pharmacy
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Aprepitant Capsules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Aprepitant Capsules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aprepitant Capsules sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Aprepitant Capsules Product Introduction

1.2 Market by Type

1.2.1 Global Aprepitant Capsules Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 80mg

1.2.3 125mg

1.2.4 Other

1.3 Market by Application

1.3.1 Global Aprepitant Capsules Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Aprepitant Capsules Sales Estimates and Forecasts 2019-2030

2.2 Global Aprepitant Capsules Revenue by Region

2.2.1 Global Aprepitant Capsules Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Aprepitant Capsules Revenue by Region (2019-2024)

2.2.3 Global Aprepitant Capsules Revenue by Region (2025-2030)

2.2.4 Global Aprepitant Capsules Revenue Market Share by Region (2019-2030)

2.3 Global Aprepitant Capsules Sales Estimates and Forecasts 2019-2030

2.4 Global Aprepitant Capsules Sales by Region

2.4.1 Global Aprepitant Capsules Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Aprepitant Capsules Sales by Region (2019-2024)

2.4.3 Global Aprepitant Capsules Sales by Region (2025-2030)

2.4.4 Global Aprepitant Capsules Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Aprepitant Capsules Sales by Manufacturers

3.1.1 Global Aprepitant Capsules Sales by Manufacturers (2019-2024)

3.1.2 Global Aprepitant Capsules Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aprepitant Capsules in 2023

3.2 Global Aprepitant Capsules Revenue by Manufacturers

3.2.1 Global Aprepitant Capsules Revenue by Manufacturers (2019-2024)

3.2.2 Global Aprepitant Capsules Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Aprepitant Capsules Revenue in 2023

3.3 Global Key Players of Aprepitant Capsules, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Aprepitant Capsules Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Aprepitant Capsules, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Aprepitant Capsules, Product Offered and Application

3.8 Global Key Manufacturers of Aprepitant Capsules, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Aprepitant Capsules Sales by Type

4.1.1 Global Aprepitant Capsules Historical Sales by Type (2019-2024)

4.1.2 Global Aprepitant Capsules Forecasted Sales by Type (2025-2030)

4.1.3 Global Aprepitant Capsules Sales Market Share by Type (2019-2030)

4.2 Global Aprepitant Capsules Revenue by Type

4.2.1 Global Aprepitant Capsules Historical Revenue by Type (2019-2024)

4.2.2 Global Aprepitant Capsules Forecasted Revenue by Type (2025-2030)

4.2.3 Global Aprepitant Capsules Revenue Market Share by Type (2019-2030)

4.3 Global Aprepitant Capsules Price by Type

4.3.1 Global Aprepitant Capsules Price by Type (2019-2024)

4.3.2 Global Aprepitant Capsules Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Aprepitant Capsules Sales by Application

5.1.1 Global Aprepitant Capsules Historical Sales by Application (2019-2024)

5.1.2 Global Aprepitant Capsules Forecasted Sales by Application (2025-2030)

5.1.3 Global Aprepitant Capsules Sales Market Share by Application (2019-2030)

5.2 Global Aprepitant Capsules Revenue by Application

5.2.1 Global Aprepitant Capsules Historical Revenue by Application (2019-2024)

5.2.2 Global Aprepitant Capsules Forecasted Revenue by Application (2025-2030)

5.2.3 Global Aprepitant Capsules Revenue Market Share by Application (2019-2030)

5.3 Global Aprepitant Capsules Price by Application

5.3.1 Global Aprepitant Capsules Price by Application (2019-2024)

5.3.2 Global Aprepitant Capsules Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Aprepitant Capsules Market Size by Type

6.1.1 US & Canada Aprepitant Capsules Sales by Type (2019-2030)

6.1.2 US & Canada Aprepitant Capsules Revenue by Type (2019-2030)

6.2 US & Canada Aprepitant Capsules Market Size by Application

6.2.1 US & Canada Aprepitant Capsules Sales by Application (2019-2030)

6.2.2 US & Canada Aprepitant Capsules Revenue by Application (2019-2030)

6.3 US & Canada Aprepitant Capsules Market Size by Country

6.3.1 US & Canada Aprepitant Capsules Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Aprepitant Capsules Sales by Country (2019-2030)

6.3.3 US & Canada Aprepitant Capsules Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Aprepitant Capsules Market Size by Type

7.1.1 Europe Aprepitant Capsules Sales by Type (2019-2030)

7.1.2 Europe Aprepitant Capsules Revenue by Type (2019-2030)

7.2 Europe Aprepitant Capsules Market Size by Application

7.2.1 Europe Aprepitant Capsules Sales by Application (2019-2030)

7.2.2 Europe Aprepitant Capsules Revenue by Application (2019-2030)

7.3 Europe Aprepitant Capsules Market Size by Country

7.3.1 Europe Aprepitant Capsules Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Aprepitant Capsules Sales by Country (2019-2030)

7.3.3 Europe Aprepitant Capsules Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Aprepitant Capsules Market Size

8.1.1 China Aprepitant Capsules Sales (2019-2030)

8.1.2 China Aprepitant Capsules Revenue (2019-2030)

8.2 China Aprepitant Capsules Market Size by Application

8.2.1 China Aprepitant Capsules Sales by Application (2019-2030)

8.2.2 China Aprepitant Capsules Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Aprepitant Capsules Market Size by Type

9.1.1 Asia Aprepitant Capsules Sales by Type (2019-2030)

9.1.2 Asia Aprepitant Capsules Revenue by Type (2019-2030)

9.2 Asia Aprepitant Capsules Market Size by Application

9.2.1 Asia Aprepitant Capsules Sales by Application (2019-2030)

9.2.2 Asia Aprepitant Capsules Revenue by Application (2019-2030)

9.3 Asia Aprepitant Capsules Sales by Region

9.3.1 Asia Aprepitant Capsules Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Aprepitant Capsules Revenue by Region (2019-2030)

9.3.3 Asia Aprepitant Capsules Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Aprepitant Capsules Market Size by Type

10.1.1 Middle East, Africa and Latin America Aprepitant Capsules Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Aprepitant Capsules Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Aprepitant Capsules Market Size by Application

10.2.1 Middle East, Africa and Latin America Aprepitant Capsules Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Aprepitant Capsules Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Aprepitant Capsules Sales by Country

10.3.1 Middle East, Africa and Latin America Aprepitant Capsules Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Aprepitant Capsules Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Aprepitant Capsules Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Merck

11.1.1 Merck Company Information

11.1.2 Merck Overview

11.1.3 Merck Aprepitant Capsules Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Merck Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck Recent Developments

11.2 Sandoz

11.2.1 Sandoz Company Information

11.2.2 Sandoz Overview

11.2.3 Sandoz Aprepitant Capsules Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Sandoz Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sandoz Recent Developments

11.3 Glenmark Pharmaceuticals

11.3.1 Glenmark Pharmaceuticals Company Information

11.3.2 Glenmark Pharmaceuticals Overview

11.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Glenmark Pharmaceuticals Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Glenmark Pharmaceuticals Recent Developments

11.4 Chia Tai Tianqing Pharmaceutical Group

11.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information

11.4.2 Chia Tai Tianqing Pharmaceutical Group Overview

11.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments

11.5 Qilu Pharmaceutical

11.5.1 Qilu Pharmaceutical Company Information

11.5.2 Qilu Pharmaceutical Overview

11.5.3 Qilu Pharmaceutical Aprepitant Capsules Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Qilu Pharmaceutical Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Qilu Pharmaceutical Recent Developments

11.6 Camber Pharma

11.6.1 Camber Pharma Company Information

11.6.2 Camber Pharma Overview

11.6.3 Camber Pharma Aprepitant Capsules Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Camber Pharma Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Camber Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Aprepitant Capsules Industry Chain Analysis

12.2 Aprepitant Capsules Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Aprepitant Capsules Production Mode & Process

12.4 Aprepitant Capsules Sales and Marketing

12.4.1 Aprepitant Capsules Sales Channels

12.4.2 Aprepitant Capsules Distributors

12.5 Aprepitant Capsules Customers

13 Market Dynamics

13.1 Aprepitant Capsules Industry Trends

13.2 Aprepitant Capsules Market Drivers

13.3 Aprepitant Capsules Market Challenges

13.4 Aprepitant Capsules Market Restraints

14 Key Findings in The Global Aprepitant Capsules Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Aprepitant Capsules Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 80mg

Table 3. Major Manufacturers of 125mg

Table 4. Major Manufacturers of Other

Table 5. Global Aprepitant Capsules Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Aprepitant Capsules Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Aprepitant Capsules Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Aprepitant Capsules Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Aprepitant Capsules Revenue Market Share by Region (2019-2024)

Table 10. Global Aprepitant Capsules Revenue Market Share by Region (2025-2030)

Table 11. Global Aprepitant Capsules Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Aprepitant Capsules Sales by Region (2019-2024) & (K Units)

Table 13. Global Aprepitant Capsules Sales by Region (2025-2030) & (K Units)

Table 14. Global Aprepitant Capsules Sales Market Share by Region (2019-2024)

Table 15. Global Aprepitant Capsules Sales Market Share by Region (2025-2030)

Table 16. Global Aprepitant Capsules Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Aprepitant Capsules Sales Share by Manufacturers (2019-2024)

Table 18. Global Aprepitant Capsules Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Aprepitant Capsules Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Aprepitant Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Aprepitant Capsules Price by Manufacturers 2019-2024 (US$/Unit)

Table 22. Global Aprepitant Capsules Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Aprepitant Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant Capsules as of 2023)

Table 24. Global Key Manufacturers of Aprepitant Capsules, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Aprepitant Capsules, Product Offered and Application

Table 26. Global Key Manufacturers of Aprepitant Capsules, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Aprepitant Capsules Sales by Type (2019-2024) & (K Units)

Table 29. Global Aprepitant Capsules Sales by Type (2025-2030) & (K Units)

Table 30. Global Aprepitant Capsules Sales Share by Type (2019-2024)

Table 31. Global Aprepitant Capsules Sales Share by Type (2025-2030)

Table 32. Global Aprepitant Capsules Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Aprepitant Capsules Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Aprepitant Capsules Revenue Share by Type (2019-2024)

Table 35. Global Aprepitant Capsules Revenue Share by Type (2025-2030)

Table 36. Aprepitant Capsules Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Aprepitant Capsules Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Aprepitant Capsules Sales by Application (2019-2024) & (K Units)

Table 39. Global Aprepitant Capsules Sales by Application (2025-2030) & (K Units)

Table 40. Global Aprepitant Capsules Sales Share by Application (2019-2024)

Table 41. Global Aprepitant Capsules Sales Share by Application (2025-2030)

Table 42. Global Aprepitant Capsules Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Aprepitant Capsules Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Aprepitant Capsules Revenue Share by Application (2019-2024)

Table 45. Global Aprepitant Capsules Revenue Share by Application (2025-2030)

Table 46. Aprepitant Capsules Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Aprepitant Capsules Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Aprepitant Capsules Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Aprepitant Capsules Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Aprepitant Capsules Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Aprepitant Capsules Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Aprepitant Capsules Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Aprepitant Capsules Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Aprepitant Capsules Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Aprepitant Capsules Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Aprepitant Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Aprepitant Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Aprepitant Capsules Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Aprepitant Capsules Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Aprepitant Capsules Sales by Country (2025-2030) & (K Units)

Table 61. Europe Aprepitant Capsules Sales by Type (2019-2024) & (K Units)

Table 62. Europe Aprepitant Capsules Sales by Type (2025-2030) & (K Units)

Table 63. Europe Aprepitant Capsules Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Aprepitant Capsules Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Aprepitant Capsules Sales by Application (2019-2024) & (K Units)

Table 66. Europe Aprepitant Capsules Sales by Application (2025-2030) & (K Units)

Table 67. Europe Aprepitant Capsules Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Aprepitant Capsules Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Aprepitant Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Aprepitant Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Aprepitant Capsules Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Aprepitant Capsules Sales by Country (2019-2024) & (K Units)

Table 73. Europe Aprepitant Capsules Sales by Country (2025-2030) & (K Units)

Table 74. China Aprepitant Capsules Sales by Type (2019-2024) & (K Units)

Table 75. China Aprepitant Capsules Sales by Type (2025-2030) & (K Units)

Table 76. China Aprepitant Capsules Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Aprepitant Capsules Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Aprepitant Capsules Sales by Application (2019-2024) & (K Units)

Table 79. China Aprepitant Capsules Sales by Application (2025-2030) & (K Units)

Table 80. China Aprepitant Capsules Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Aprepitant Capsules Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Aprepitant Capsules Sales by Type (2019-2024) & (K Units)

Table 83. Asia Aprepitant Capsules Sales by Type (2025-2030) & (K Units)

Table 84. Asia Aprepitant Capsules Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Aprepitant Capsules Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Aprepitant Capsules Sales by Application (2019-2024) & (K Units)

Table 87. Asia Aprepitant Capsules Sales by Application (2025-2030) & (K Units)

Table 88. Asia Aprepitant Capsules Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Aprepitant Capsules Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Aprepitant Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Aprepitant Capsules Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Aprepitant Capsules Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Aprepitant Capsules Sales by Region (2019-2024) & (K Units)

Table 94. Asia Aprepitant Capsules Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Aprepitant Capsules Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Aprepitant Capsules Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Aprepitant Capsules Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Aprepitant Capsules Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Aprepitant Capsules Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Aprepitant Capsules Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Aprepitant Capsules Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Aprepitant Capsules Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Aprepitant Capsules Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Aprepitant Capsules Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Aprepitant Capsules Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Aprepitant Capsules Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Aprepitant Capsules Sales by Country (2025-2030) & (K Units)

Table 108. Merck Company Information

Table 109. Merck Description and Major Businesses

Table 110. Merck Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Merck Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Merck Recent Developments

Table 113. Sandoz Company Information

Table 114. Sandoz Description and Major Businesses

Table 115. Sandoz Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. Sandoz Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Sandoz Recent Developments

Table 118. Glenmark Pharmaceuticals Company Information

Table 119. Glenmark Pharmaceuticals Description and Major Businesses

Table 120. Glenmark Pharmaceuticals Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. Glenmark Pharmaceuticals Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Glenmark Pharmaceuticals Recent Developments

Table 123. Chia Tai Tianqing Pharmaceutical Group Company Information

Table 124. Chia Tai Tianqing Pharmaceutical Group Description and Major Businesses

Table 125. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Chia Tai Tianqing Pharmaceutical Group Recent Developments

Table 128. Qilu Pharmaceutical Company Information

Table 129. Qilu Pharmaceutical Description and Major Businesses

Table 130. Qilu Pharmaceutical Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Qilu Pharmaceutical Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Qilu Pharmaceutical Recent Developments

Table 133. Camber Pharma Company Information

Table 134. Camber Pharma Description and Major Businesses

Table 135. Camber Pharma Aprepitant Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. Camber Pharma Aprepitant Capsules Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Camber Pharma Recent Developments

Table 138. Key Raw Materials Lists

Table 139. Raw Materials Key Suppliers Lists

Table 140. Aprepitant Capsules Distributors List

Table 141. Aprepitant Capsules Customers List

Table 142. Aprepitant Capsules Market Trends

Table 143. Aprepitant Capsules Market Drivers

Table 144. Aprepitant Capsules Market Challenges

Table 145. Aprepitant Capsules Market Restraints

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Aprepitant Capsules Product Picture

Figure 2. Global Aprepitant Capsules Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Aprepitant Capsules Market Share by Type in 2023 & 2030

Figure 4. 80mg Product Picture

Figure 5. 125mg Product Picture

Figure 6. Other Product Picture

Figure 7. Global Aprepitant Capsules Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Aprepitant Capsules Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Other

Figure 12. Aprepitant Capsules Report Years Considered

Figure 13. Global Aprepitant Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Aprepitant Capsules Revenue 2019-2030 (US$ Million)

Figure 15. Global Aprepitant Capsules Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Aprepitant Capsules Revenue Market Share by Region (2019-2030)

Figure 17. Global Aprepitant Capsules Sales 2019-2030 ((K Units)

Figure 18. Global Aprepitant Capsules Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Aprepitant Capsules Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Aprepitant Capsules Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Aprepitant Capsules Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Aprepitant Capsules Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Aprepitant Capsules Sales YoY (2019-2030) & (K Units)

Figure 24. China Aprepitant Capsules Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Aprepitant Capsules Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Aprepitant Capsules Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Aprepitant Capsules Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Aprepitant Capsules Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Aprepitant Capsules Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Aprepitant Capsules in the World: Market Share by Aprepitant Capsules Revenue in 2023

Figure 31. Global Aprepitant Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Aprepitant Capsules Sales Market Share by Type (2019-2030)

Figure 33. Global Aprepitant Capsules Revenue Market Share by Type (2019-2030)

Figure 34. Global Aprepitant Capsules Sales Market Share by Application (2019-2030)

Figure 35. Global Aprepitant Capsules Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Aprepitant Capsules Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Aprepitant Capsules Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Aprepitant Capsules Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Aprepitant Capsules Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Aprepitant Capsules Revenue Share by Country (2019-2030)

Figure 41. US & Canada Aprepitant Capsules Sales Share by Country (2019-2030)

Figure 42. U.S. Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Aprepitant Capsules Sales Market Share by Type (2019-2030)

Figure 45. Europe Aprepitant Capsules Revenue Market Share by Type (2019-2030)

Figure 46. Europe Aprepitant Capsules Sales Market Share by Application (2019-2030)

Figure 47. Europe Aprepitant Capsules Revenue Market Share by Application (2019-2030)

Figure 48. Europe Aprepitant Capsules Revenue Share by Country (2019-2030)

Figure 49. Europe Aprepitant Capsules Sales Share by Country (2019-2030)

Figure 50. Germany Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 51. France Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 55. China Aprepitant Capsules Sales Market Share by Type (2019-2030)

Figure 56. China Aprepitant Capsules Revenue Market Share by Type (2019-2030)

Figure 57. China Aprepitant Capsules Sales Market Share by Application (2019-2030)

Figure 58. China Aprepitant Capsules Revenue Market Share by Application (2019-2030)

Figure 59. Asia Aprepitant Capsules Sales Market Share by Type (2019-2030)

Figure 60. Asia Aprepitant Capsules Revenue Market Share by Type (2019-2030)

Figure 61. Asia Aprepitant Capsules Sales Market Share by Application (2019-2030)

Figure 62. Asia Aprepitant Capsules Revenue Market Share by Application (2019-2030)

Figure 63. Asia Aprepitant Capsules Revenue Share by Region (2019-2030)

Figure 64. Asia Aprepitant Capsules Sales Share by Region (2019-2030)

Figure 65. Japan Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 69. India Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Aprepitant Capsules Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Aprepitant Capsules Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Aprepitant Capsules Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Aprepitant Capsules Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Aprepitant Capsules Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Aprepitant Capsules Sales Share by Country (2019-2030)

Figure 76. Brazil Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Aprepitant Capsules Revenue (2019-2030) & (US$ Million)

Figure 81. Aprepitant Capsules Value Chain

Figure 82. Aprepitant Capsules Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Aprepitant Capsules market? zhanKai

The top companies in the global Aprepitant Capsules market are Merck、Sandoz、Glenmark Pharmaceuticals.

Related Reports

Global Aprepitant Capsules Market Research Report 2025
The global market for Aprepitant Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 87
USD 2900.00
(Single User License)
Global Aprepitant Capsules Market Research Report 2024
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-01-17
Pages: 77
USD 2900.00
(Single User License)
Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published Date: 2024-01-10
Pages: 105
USD 3950.00
(Single User License)

Global Aprepitant Capsules Market Research Report 2025
The global market for Aprepitant Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 87
USD 2900.00 (Single User License)
Global Aprepitant Capsules Market Research Report 2024
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-01-17
Pages: 77
USD 2900.00 (Single User License)
Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
Published: 2024-01-10
Pages: 105
USD 3950.00 (Single User License)